Immediate Impact
1 from Science/Nature 68 standout
Citing Papers
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
Lung cancer statistics, 2023
2024 Standout
Works of Gabriel Mak being referenced
ADRIATIC: A phase III trial of durvalumab ± tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer
2019
Towards an Optimal Treatment Algorithm for Metastatic Pancreatic Ductal Adenocarcinoma (PDA)
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Gabriel Mak | 188 | 41 | 69 | 97 | 20 | 275 | |
| S Aizawa | 142 | 58 | 72 | 133 | 23 | 335 | |
| Daniela Bianconi | 159 | 48 | 64 | 100 | 23 | 301 | |
| Nicola Decarli | 127 | 75 | 57 | 103 | 17 | 295 | |
| Kaiwen Chi | 159 | 30 | 80 | 98 | 17 | 299 | |
| P. G. Knapstein | 137 | 72 | 33 | 82 | 24 | 335 | |
| Lihou Dong | 160 | 34 | 56 | 84 | 19 | 280 | |
| Yasuyuki Okada | 152 | 56 | 89 | 101 | 20 | 274 | |
| Clay M. Anderson | 133 | 17 | 71 | 95 | 12 | 289 | |
| T Toge | 141 | 92 | 113 | 113 | 29 | 321 | |
| Hideo Tomihara | 128 | 60 | 63 | 134 | 23 | 273 |
All Works
Loading papers...